학술논문
6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial
Document Type
Article
Author
Earl, H.M.; Hughes-Davies, L.; Abraham, J.E.; Caldas, C.; Mahler-Araujo, B.; Vallier, A.-L.; McAdam, K.; Provenzano, E.; Chhabra, A.; Hiller, L.; Loi, S.; Howe, D.; Raynes, K.; Higgins, H.B.; Dunn, J.A.; Harnett, A.N.; Ah-See, M.-L.; Miles, D.; Simcock, R.; Rea, D.; Raj, S.; Woodings, P.; Harries, M.; Mansi, J.; Wilcox, M.; Plummer, C.; Gounaris, I.; Hall, P.S.; Cameron, D.A.; McCabe, C.; Hulme, C.; Wardley, A.M.; Agarwal, R.; Algurafi, H.; Allerton, R.; Archer, C.; Armstrong, A.; Bale, C.; Barraclough, L.; Barthakur, U.; Bedi, C.; Benstead, K.; Bloomfield, D.; Bowen, R.; Bradley, C.; Brown, J.; Butt, M.; Churn, M.; Cleator, S.; Cliff, J.; Crellin, P.; Daly, M.; De Silva-Minor, S.; Dhadda, A.; Din, O.; Down, S.; Earl, H.; Eaton, D.; Eichholz, A.; Epurescu, D.; Goh, C.; Goodman, A.; Grieve, R.; Hadaki, M.; Harper-Wynne, C.; Hayward, L.; Humphreys, A.; Innes, H.; Jafri, M.; Jegannathen, A.; Kelleher, M.; Kristeleit, H.; Lee, D.; Lupton, S.; MacGregor, C.; Malik, Z.; Marshall, J.; McGolick, T.; Mehra, R.; Mithal, N.; Moss, C.; Moss, A.; Mukesh, M.; Neal, A.; Nelmes, D.; Neville-Webbe, H.; Newby, J.; O'Reilly, S.; Ostler, P.; Persic, M.; Pettit, L.; Raja, F.; Reed, C.; Rigg, A.; Roe, H.; Shah, N.; Simmonds, P.; Sims, E.; Smith, S.; Storey, N.; Taylor, W.; Thanvi, N.; Tipples, K.; Vaidya, J.; Varughese, M.; Vinayan, A.; Walji, N.; Waters, S.; Wright, K.; Yahya, S.
Source
In: The Lancet . (The Lancet, 29 June - 5 July 2019, 393(10191):2599-2612)
Subject
Language
English
ISSN
1474547X
01406736
01406736